Preoperative Chemoradiation for the Treatment of Locoregional Esophageal Cancer: The Standard of Care?

Seminars in Radiation Oncology

Volumn 17, Issue 1, 2007, Pages 45-52

  Schneider, Bryan J ^a   Urba, Susan G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

localized esophageal cancer; neoadjuvant therapy; review

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; VINCRISTINE;

ARTICLE; CANCER MORTALITY; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS;

EID: 33845512731     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.09.002     Document Type: Article

References (34)

1. Jemal A., Murray T., and Ward E. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Kasai M., Mori S., and Watanabe T. Follow up results after resections of thoracic esophageal cancer. World J Surg 2 (1978) 543-551
3. Earlan F., and Cunha-Mejo R. Oesophageal squamous cell carcinoma: A critical review of surgery. Br J Surg 67 (1980) 381-390
4. Orringer M.B. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 200 (1984) 282-288
5. Orringer M.B., Marshall B., and Iannettoni M.D. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 230 (1999) 392-400
6. Walsh T.N., Noonan N., and Hollywood D. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
7. Apinop C., Puttisak P., and Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41 (1994) 391-393
8. Nygaard K., Hagen S., Hansen H.S., and The second Scandinavian trial in esophageal cancer. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. World J Surg 16 (1992) 1104-1110
9. Urba S., Orringer M., and Turrisi. A randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
10. Bosset J.F., Gignoux M., and Triboulet J.P. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
11. Burmeister B.H., Smithers B.M., and Gebski V. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomized controlled phase III trial. Lancet Oncol 6 (2005) 659-668
12. Le Prise E., Etienne P.L., and Meunier B. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1779-1784
13. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 359 (2002) 1727-1733
14. Kok T.C., van Lanschot J., and Siersma P.D. Neo-adjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized trial. Proc Am Soc Oncol 16 (1997) 227 (abstr)
15. Kelsen D.P., Ginsberg R., and Pajak T.F. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1979-1984
16. Law S.M.B., Fok M., and Chow S. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial. J Thorac Cardovasc Surg 114 (1997) 210-217
17. Ancona E., Ruol A., and Santi S. Only pathologic complete response to neo-adjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma. Cancer 91 (2001) 2165-2174
18. Cunningham D., Allum W.H., and Stenning S.P. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomized, controlled trial (the MAGIC trial, ISRCTN 93793971). Proc Am Soc Oncol 23 (2005) 16s (abstr 4001)
19. Launois B., Delarue D., and Campion J.P. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153 (1981) 690-692
20. Paillot B. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C. Gignoux M Roussel A. World J Surg 11 (1987) 426-432
21. Huang G.J., Gu X.Z., and Wang L.J. Experience with combined preoperative irradiation and surgery for carcinoma of the esophagus. Gan Monogr Cancer Res 31 (1986) 159-164
22. Arnott S.J., Duncan W., and Gignoux M. Preoperative Radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (oesophageal cancer collaborative group). Int J Radiat Oncol Biol Phys 41 (1998) 579-583
23. Krasna M., Tepper J.E., and Niedzwiecki D. Trimodality therapy is superior to surgery alone in esophageal cancer: Results of CALGB 9781 (2006) Presened at the 3rd annual American Society of Clinical Oncology Gastrointestinal Cancers Symposium. San Francisco, CA, January 26-28
24. Urschel J.D., and Vasan H.B. A meta-analysis of randomized controlled trials that compared neo-adjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185 (2003) 538-543
25. Fiorica F., Di Bona D., and Schepis F. Preoperative chemoradiotherapy for oesophageal cancer: A systemic review and meta-analysis. Gut 53 (2004) 925-930
26. MacDonald J.S., Smalley S.R., and Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
27. Bedenne L., Michel P., and Bouche O. Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol 21 (2002) 519 (abstr)
28. Stahl M., Stuschke M., and Lehmann N. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
29. Vogel S.B., Mendenhall W.M., and Sombeck M.D. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 221 (1995) 685-695
30. Triboulet J.P., Amrouni H., and Guillem P. Devenir des cancers epidermoides de l'oesophage en responsif complète après chimioradiotherapie pre-operatoire. Ann Chir 52 (1998) 503-508
31. Forastiere A.A., Heitmiller R.F., and Kleinberg G.L. Multimodality therapy for esophageal cancer. Chest 112 (1997) 195S-200S
32. Berger A.C., Farma J., and Scott W.J. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23 (2005) 4330-4337
33. Urba S.G., Orringer M.B., and Ianettonni M. Concurrent cisplatin, paclitaxel and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma. Cancer 98 (2003) 2177-2183
34. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, v. 1.2006. Esophageal Cancer, http://www.nccn.org/professionals/physician_gls/PDF/esophagel.pdf (accessed 11/6/06).